TCR γ/δ+ separation from TCR α/ß+ with MARS® Bar

In recent years T cell receptor (TCR) cell therapy has gained popularity due to a range of possible treatments for cancer and some infectious diseases it could provide. Since γδ T-cells constitute promising effector cell compartments for cancer immunotherapy, novel γδ T-cell-based immunotherapies are being developed. Although advancements in TCR engineering, manufacturing, and clinical applications have led to […]

MARS® MAG Premium Line

MARS® MAG Premium Line is a family of cell separation reagent kits launched in collaboration with STEMCELL Technologies. These reagents have been shown to enable fast and easy isolation of many cell types, including granulocytes, NK cells, and plasma cells. With protocols optimized for the MARS instruments, the kits provide an integrated cell isolation solution. This is especially […]

MARS® Ingenuity™ Line of Reagents brochure

MARS® Ingenuity™ Line is a family of cell isolation reagent kits launched in collaboration with GenScript USA Inc. aiming to deliver combined solutions for cell therapy drug development worldwide. The kits include research and cGMP-grade reagents for fast and easy cell isolation supporting the development of CAR-T and other Cell Therapy products on the MARS® […]

CD3- CD56+ NK Cell Selection with MARS® Platform

NK cells are currently a major target of innovation in the field of cancer immunotherapy. Efforts aimed at developing and engineering NK cell-based cancer immunotherapy require clean and efficient methods of cell isolation at both small and large scales. The new MARS® Bar system enables a new generation of large scale, magnetic CD56+/CD3- cell isolation […]

High Purity Plasma CD138+ Cell Isolation straight from Whole Blood

Characterization of Plasma Cells in Bone Marrow (BM) for cytogenetic abnormalities is a common genetic test to diagnose and monitor multiple myeloma (MM). Plasma cells in MM patients vary in proportion from <1% up to 100%. Even though Circulating Plasma Cells (CPCs) burden in peripheral blood is reported to be >100-fold lower than in BM, their presence […]

High Efficiency Separation of CD34+ HSC from Mobilized Blood

In recent years multipotent haematopoietic stem cell (HSC) therapy has become a popular technique with a range of promising health benefits. A broad variety of possibilities makes this cutting-edge therapy a turning point in modern medicine. One of the recognized challenges is the ability to quickly obtain a sufficient number of desired cell types for transplantation, with […]